Networked & Personalized - the future of biotech?
During BIO2012 last week, Ernst & Young presented their annual Beyond Borders report on the state of the biotech industry. Several themes are covered in the report but the underlying trend is a much broader discussion and movement towards open sharing of data and collaboration across academia, industry, patient advocacy groups and payors. This "networked innovation" aligns biotech with high tech's much broader use of data and personalized targeting that we see at work in social networks and online advertising every day and has enormous opportunity to increase timelines and success rates in drug development.
Barbara Lavery
|
June 25, 2012
Biotech
|
Personalized Medicine
|
Pharma
Strong Brands Help Retain Top Talent
Of the many challenges facing companies during a recession, employee retention isn’t always at the top of the list. Maintaining morale during times of cost cuts, furloughs and layoffs often takes priority — especially amidst so much uncertainty, when most people aren’t actively looking to switch careers.
Dillon Allie
|
December 01, 2010
Branding
|
Business
Pharma is Tweeting, Are You Following?
A recent report shows Pharma companies to be taking a larger presence in social media than ever before. Not only are pharma companies bigger in overall presence (follower numbers, corporate participation and evolution of expertise), the trends and involvement is becoming more impactful.
HDMZ SEO Team
|
July 27, 2015
Marketing
|
HDMZ
|
SEO
|
Twitter
Deliver a Successful Investor Presentation
Does your investor presentation clearly articulate your passion, commitment and value in 20 minutes or less? The development and delivery of a presentation plays a critical part in getting the attention you want and deserve. Every company has a different story to tell, but most of the time the presentations are in the same format, in the same room, and to the same people. Our team has had the privilege of watching and developing biotech company presentations for over 15 years.
HDMZ Staff
|
March 25, 2013
Corporate Communications
|
Biotech
|
Pharma
|
Investor Presentations
|
Investor Relations